/Investor DB

Healthspan Capital

Venture capital

Oxford · Seed–Series A · 2 people tracked

Find your way into Healthspan Capital

Each arrow is one introduction. Sign up to fill in the first one.

1,420 people can intro you to Sebastian

Ask Marija Zecevic to introduce you to Sebastian Brunemeier

You →Marija · together at Samsara Therapeutics →Sebastian

211 people can intro you to Colin

Ask Jamie Chen to introduce you to Colin Maraganore

You →Jamie · together at quadraScope Venture Fund →Colin

Sign up to find every way you can get introduced to Healthspan Capital

  • Your email: who you already know at Healthspan Capital, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Healthspan Capital team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Healthspan Capital invests in a diversified portfolio of early-stage longevity biotechnology companies developing novel approaches to address aging, disease, and human lifespan. The fund leverages deep expertise in longevity biotech company creation and investment, backed by an extensive network of collaborators, advisors, and founders in the space. The rolling fund structure provides simple and flexible access for investors to participate in the longevity biotech sector.

Source: firm website, verified Aug 6, 2026.

Stage
Seed–Series A
Check
$5K
HQ
Oxford, GB
Instruments
Equity
Founded
2021
Last 12 months
1 investment
Tracked investments
5

Team · 2 people

from curated & public directories

What they invest in

from 4 of 5 portfolio companies

Biotech ×4Healthtech ×4Deep Tech ×3AI & Machine Learning ×2Longevity ×1Medical Devices ×1

HQs:United States×4

Investments · 5 tracked

founders shown can be your intro path

By year:2026 · 12025 · 22023 · 12021 · 15 dated

Fauna Biofaunabio.cominSeed · Sep 2021 · $9M

Fauna Bio applies AI and computational analysis to its proprietary biobank of data from extreme mammals such as hibernating species to identify drug targets that are conserved across species including humans.

AI & Machine LearningBiotechDeep TechHealthtechEmeryville, US

Linda Goodman(Founder)inAshley(CEO)

Co-investorsage1Farvatn VentureGRIDS CapitalLifeforce CapitalMetaplanetPalo Santo VC+4 more

ImmuneBridgeimmunebridge.comMar 2026 · $7.7M

ImmuneBridge is a company working in cell-based cancer immunotherapy, including research on engineered natural killer cells for solid tumor treatment.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSan Francisco, US

Peretz Partensky(Executive Officer, Director)inStuart Alexander Jacobson(Executive Officer, Director)Nina Horowitz(Chief Executive Officer)inRui Tostoes(Chief Technology Officer)inAlicia Jackson(Director)in

BoardDylan Morris(Director)in

Co-investorsM VenturesNFXPioneerGaingelsInsight PartnersOne Way Ventures+1 more

Modulate Biomodulatebio.cominPre-Seed · Aug 2025

Modulate Bio develops small-molecule GABAA positive allosteric modulators to treat neurological disorders including Essential Tremor, epilepsy, and anxiety.

BiotechDeep TechHealthtechAllston, US

Dario Doller(Co-founder)inKevin Hodgetts(Founding Lab / Co-founder)inAndrew Thomson(Executive Officer, Director, Promoter)in

Co-investorsPillar VCPalo Santo VC

Oisin Biotechnologiesoisinbio.comSeries A · Aug 2025 · $10M

Oisín Biotechnologies develops non-viral genetic therapies built on its Fusogenix Proteo-Lipid Vehicle (PLV) delivery platform, which delivers DNA and RNA payloads to tissues throughout the body and allows repeat dosing.

BiotechHealthtechLongevitySeattle, US

Matthew Scholz(Executive Officer, Director)inEric Garcia(Executive Officer)inStephen Hilbert(Executive Officer)John Lewis(Executive Officer)inGary Hudson(Executive Officer, Director)in

BoardDavid Gobel(Director)

Co-investorsIKJ Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Jung+ Longevity

Frequently asked questions

How many investments has Healthspan Capital made?
Healthspan Capital has 5 tracked investments, including 3 dated in the last 24 months.
What stage does Healthspan Capital invest at?
Healthspan Capital invests at the Seed, Series A stages.
What is Healthspan Capital's typical check size?
Healthspan Capital typically writes checks of $5K.
What sectors does Healthspan Capital focus on?
Healthspan Capital focuses on Biotech, Longevity.
Where is Healthspan Capital located?
Healthspan Capital is headquartered in Oxford, GB.

Media · Podcasts & interviews

featuring the team

Sebastian Brunemeier, Partner at HealthSpan Capital talks to IBTV at Advanced Therapies Europe 2024

IBTV · Sebastian Brunemeier

Similar investors

Featured in lists